[
    [
        {
            "time": "2020-01-03",
            "original_text": "Can Biotech ETFs Continue to Soar in 2020?",
            "features": {
                "keywords": [
                    "Biotech",
                    "ETFs",
                    "Soar"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 4,
                "Sentiment": 8,
                "Importance": 5,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-02-15",
            "original_text": "J&J Brand Most Valuable Among Pharmaceutical Companies",
            "features": {
                "keywords": [
                    "J&J",
                    "Brand",
                    "Valuable",
                    "Pharmaceutical"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceutical"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-03-12",
            "original_text": "Jury orders Johnson & Johnson to pay $750 million in New Jersey talc case",
            "features": {
                "keywords": [
                    "Johnson & Johnson",
                    "pay",
                    "750 million",
                    "talc",
                    "case"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceutical"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 1,
                "Importance": 8,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-03-14",
            "original_text": "J&J ordered to pay $750 mln in NJ talc case -lawyer",
            "features": {
                "keywords": [
                    "J&J",
                    "ordered",
                    "pay",
                    "750 mln",
                    "talc",
                    "case"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceutical"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 1,
                "Importance": 8,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-01-10",
            "original_text": "64 Best Dividend Stocks You Can Count On in 2020",
            "features": {
                "keywords": [
                    "Dividend",
                    "Stocks",
                    "Count",
                    "2020"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "dividend"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 4,
                "Impact": 4,
                "Duration": 8,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-02-20",
            "original_text": "Glaxo (GSK) Lags Q4 Earnings & Revenue Estimates, Stock Down",
            "features": {
                "keywords": [
                    "Glaxo",
                    "GSK",
                    "Lags",
                    "Q4",
                    "Earnings",
                    "Revenue",
                    "Estimates",
                    "Stock",
                    "Down"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceutical"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]